Xellsmart
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $115M
Investors
- 25
About Xellsmart
, trading as Xellsmart, operates as a stem cell medical services provider that provides stem cell therapy solutions. It has R&D center located in Shanghai and GMP pilot plant and quality control center. It cooperates with Tongji University, Beckley and Peking University, etc. The founder, Xiang Li, graduated from the School of Life Sciences at Peking University and used to work for Sana Biotechnology. In August 2022, the company has been recognized the top 10 most growing innovative therapy companies. The company adopts reprogramming technology and provides stem cell therapy solutions for patients with Parkinson's disease. Its products include iPS cell line reprogramming, iPSC gene editing platform and pluripotent stem cell induced differentiation platform and the construction of preclinical disease animal models. The company generates revenue by providing stem cell therapy solutions.
Who invested in Xellsmart
25 investors across 6 rounds
See all investors in Xellsmart
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xellsmart
Who invested in Xellsmart?
Xellsmart has 25 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xellsmart raised?
Xellsmart has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Xellsmart last raise money?
Xellsmart's most recent round on record is a Series C, in Apr 2026.
What does Xellsmart do?
, trading as Xellsmart, operates as a stem cell medical services provider that provides stem cell therapy solutions.
Where is Xellsmart headquartered?
Xellsmart is headquartered in Suzhou, China.
Which VCs invest in companies like Xellsmart?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Xellsmart's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Xellsmart? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.